Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 31 - 40 of 808 items for :

  • hormone therapy x
Clear All
Henryk F Urbanski Division of Neuroscience, Oregon National Primate Research Center, Beaverton, Oregon, USA
Division of Reproductive & Developmental Sciences, Oregon National Primate Research Center, Beaverton, Oregon, USA
Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, Oregon, USA
Department of Physiology & Pharmacology, Oregon Health & Science University, Portland, Oregon, USA

Search for other papers by Henryk F Urbanski in
Google Scholar
PubMed Close
,
Kevin Mueller Division of Reproductive & Developmental Sciences, Oregon National Primate Research Center, Beaverton, Oregon, USA

Search for other papers by Kevin Mueller in
Google Scholar
PubMed Close
, and
Cynthia L Bethea Division of Neuroscience, Oregon National Primate Research Center, Beaverton, Oregon, USA
Division of Reproductive & Developmental Sciences, Oregon National Primate Research Center, Beaverton, Oregon, USA
Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon, USA

Search for other papers by Cynthia L Bethea in
Google Scholar
PubMed Close

– 867 . ( doi:10.1016/j.neuroscience.2005.09.006 ) 4 Voytko ML Higgs CJ Murray R . Differential effects on visual and spatial recognition memory of a novel hormone therapy regimen of estrogen alone or combined with progesterone in older

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0108
Volume/Issue:
Volume 6: Issue 6
Open access
Magdalena Lech Faculty of Life Sciences and Medicine, School of Life Course Sciences, King’s College London, London, UK

Search for other papers by Magdalena Lech in
Google Scholar
PubMed Close
,
Ruvini Ranasinghe Department of Clinical Biochemistry, King’s College Hospital NHS Foundation Trust, Denmark Hill, London, UK

Search for other papers by Ruvini Ranasinghe in
Google Scholar
PubMed Close
,
Royce P Vincent Department of Clinical Biochemistry, King’s College Hospital NHS Foundation Trust, Denmark Hill, London, UK
Faculty of Life Sciences and Medicine, School of Life Course Sciences, King’s College London, London, UK

Search for other papers by Royce P Vincent in
Google Scholar
PubMed Close
,
David R Taylor Department of Clinical Biochemistry, King’s College Hospital NHS Foundation Trust, Denmark Hill, London, UK

Search for other papers by David R Taylor in
Google Scholar
PubMed Close
,
Lea Ghataore Department of Clinical Biochemistry, King’s College Hospital NHS Foundation Trust, Denmark Hill, London, UK

Search for other papers by Lea Ghataore in
Google Scholar
PubMed Close
,
James Luxton Department of Clinical Biochemistry, King’s College Hospital NHS Foundation Trust, Denmark Hill, London, UK

Search for other papers by James Luxton in
Google Scholar
PubMed Close
,
Fannie Lajeunesse-Trempe Department of Endocrinology ASO/EASO COM, King's College Hospital NHS Foundation Trust, Denmark Hill, London, UK
Quebec Heart and Lung Institute, Laval University, Quebec, Canada

Search for other papers by Fannie Lajeunesse-Trempe in
Google Scholar
PubMed Close
,
Pia Roser Department of Endocrinology and Diabetes, University Medical Centre Hamburg Eppendorf, Hamburg, Germany

Search for other papers by Pia Roser in
Google Scholar
PubMed Close
,
Eftychia E Drakou Department of Clinical Oncology, Guy's Cancer Centre - Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London, UK

Search for other papers by Eftychia E Drakou in
Google Scholar
PubMed Close
,
Ling Ling Chuah Department of Endocrinology ASO/EASO COM, King's College Hospital NHS Foundation Trust, Denmark Hill, London, UK

Search for other papers by Ling Ling Chuah in
Google Scholar
PubMed Close
,
Ashley B Grossman Green Templeton College, University of Oxford, Oxford, UK
Barts and the London School of Medicine, Centre for Endocrinology, William Harvey Institute, London, UK
Neuroendocrine Tumour Unit, Royal Free Hospital, London, UK

Search for other papers by Ashley B Grossman in
Google Scholar
PubMed Close
,
Simon J B Aylwin Department of Endocrinology ASO/EASO COM, King's College Hospital NHS Foundation Trust, Denmark Hill, London, UK

Search for other papers by Simon J B Aylwin in
Google Scholar
PubMed Close
, and
Georgios K Dimitriadis Department of Endocrinology ASO/EASO COM, King's College Hospital NHS Foundation Trust, Denmark Hill, London, UK
Obesity, Type 2 Diabetes and Immunometabolism Research Group, School of Cardiovascular and Metabolic Medicine & Sciences, Faculty of Life Course Sciences, King’s College London, London, UK
Division of Reproductive Health, Warwick Medical School, University of Warwick, Coventry, UK

Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed Close

mitotane therapy frequently being offered glucocorticoid replacement therapy ( 2 ). Whilst the existing literature quite clearly demonstrates the impact of mitotane on steroids and hormone-binding proteins, to date, no studies have specifically related

Article Type:
Research Article
Collections:
Adrenal
DOI:
https://doi.org/10.1530/EC-23-0159
Volume/Issue:
Volume 13: Issue 3
Open access
Julie M Silverstein Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8127, St Louis, Missouri 63110, USA

Search for other papers by Julie M Silverstein in
Google Scholar
PubMed Close

have achieved normal hormonal levels after multimodal treatment, active monitoring is essential to follow the effects of therapy and maintain their benefit. Furthermore, detection of persistent or recurrent disease is compromised when patients are not

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-15-0064
Volume/Issue:
Volume 4: Issue 4
Open access
Henrik H Thomsen Medical Research Laboratories, Departments of Clinical Biochemistry, Molecular Medicine, Department of Clinical Genetics, Department of Endocrinology and Internal Medicine, Clinical Institute, Aarhus University Hospital, Nørrebrogade 44, DK-8000 Aarhus C, Denmark

Search for other papers by Henrik H Thomsen in
Google Scholar
PubMed Close
,
Holger J Møller Medical Research Laboratories, Departments of Clinical Biochemistry, Molecular Medicine, Department of Clinical Genetics, Department of Endocrinology and Internal Medicine, Clinical Institute, Aarhus University Hospital, Nørrebrogade 44, DK-8000 Aarhus C, Denmark

Search for other papers by Holger J Møller in
Google Scholar
PubMed Close
,
Christian Trolle Medical Research Laboratories, Departments of Clinical Biochemistry, Molecular Medicine, Department of Clinical Genetics, Department of Endocrinology and Internal Medicine, Clinical Institute, Aarhus University Hospital, Nørrebrogade 44, DK-8000 Aarhus C, Denmark

Search for other papers by Christian Trolle in
Google Scholar
PubMed Close
,
Kristian A Groth Medical Research Laboratories, Departments of Clinical Biochemistry, Molecular Medicine, Department of Clinical Genetics, Department of Endocrinology and Internal Medicine, Clinical Institute, Aarhus University Hospital, Nørrebrogade 44, DK-8000 Aarhus C, Denmark

Search for other papers by Kristian A Groth in
Google Scholar
PubMed Close
,
Anne Skakkebæk Medical Research Laboratories, Departments of Clinical Biochemistry, Molecular Medicine, Department of Clinical Genetics, Department of Endocrinology and Internal Medicine, Clinical Institute, Aarhus University Hospital, Nørrebrogade 44, DK-8000 Aarhus C, Denmark

Search for other papers by Anne Skakkebæk in
Google Scholar
PubMed Close
,
Anders Bojesen Medical Research Laboratories, Departments of Clinical Biochemistry, Molecular Medicine, Department of Clinical Genetics, Department of Endocrinology and Internal Medicine, Clinical Institute, Aarhus University Hospital, Nørrebrogade 44, DK-8000 Aarhus C, Denmark

Search for other papers by Anders Bojesen in
Google Scholar
PubMed Close
,
Christian Høst Medical Research Laboratories, Departments of Clinical Biochemistry, Molecular Medicine, Department of Clinical Genetics, Department of Endocrinology and Internal Medicine, Clinical Institute, Aarhus University Hospital, Nørrebrogade 44, DK-8000 Aarhus C, Denmark

Search for other papers by Christian Høst in
Google Scholar
PubMed Close
, and
Claus H Gravholt Medical Research Laboratories, Departments of Clinical Biochemistry, Molecular Medicine, Department of Clinical Genetics, Department of Endocrinology and Internal Medicine, Clinical Institute, Aarhus University Hospital, Nørrebrogade 44, DK-8000 Aarhus C, Denmark
Medical Research Laboratories, Departments of Clinical Biochemistry, Molecular Medicine, Department of Clinical Genetics, Department of Endocrinology and Internal Medicine, Clinical Institute, Aarhus University Hospital, Nørrebrogade 44, DK-8000 Aarhus C, Denmark

Search for other papers by Claus H Gravholt in
Google Scholar
PubMed Close

controls. The design was a randomized crossover study. Both groups underwent a 2 month wash-out period from hormone replacement therapy (HRT) and oral contraceptive therapy (OCT) respectively. Subjects were examined at the end of each 2-month period. The

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-13-0067
Volume/Issue:
Volume 2: Issue 4
Open access
Salman Razvi Translational and Clinical Research Institute, University of Newcastle, Newcastle-upon-Tyne, UK

Search for other papers by Salman Razvi in
Google Scholar
PubMed Close
,
Sanaa Mrabeti Medical Affairs EMEA, Merck Serono Middle East FZ-LLC, Dubai, United Arab Emirates

Search for other papers by Sanaa Mrabeti in
Google Scholar
PubMed Close
, and
Markus Luster Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany

Search for other papers by Markus Luster in
Google Scholar
PubMed Close

true malabsorption from patients with poor adherence to therapy ( 85 ). Liver cirrhosis also increases the dose requirement for LT4 ( 86 , 87 ). Numerous medications alter the metabolism or excretion of thyroid hormones, and can influence circulating

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-20-0205
Volume/Issue:
Volume 9: Issue 11
Open access
Ruth Percik Institute of Endocrinology, Diabetes and Metabolism, Sheba Medical Centre, Ramat Gan, Israel

Search for other papers by Ruth Percik in
Google Scholar
PubMed Close
,
Sherwin Criseno Department of Endocrinology, University Hospital Birmingham, Birmingham, UK

Search for other papers by Sherwin Criseno in
Google Scholar
PubMed Close
,
Safwaan Adam Department of Endocrinology, The Christie NHS Foundation Trust, Manchester, UK

Search for other papers by Safwaan Adam in
Google Scholar
PubMed Close
,
Kate Young Royal Marsden Hospital, London, UK

Search for other papers by Kate Young in
Google Scholar
PubMed Close
, and
Daniel L Morganstein Department of Endocrinology, Chelsea and Westminster Hospital, London, UK
Royal Marsden Hospital, London, UK

Search for other papers by Daniel L Morganstein in
Google Scholar
PubMed Close

predominately on symptom severity at presentation is not helpful in guiding decisions about hormone replacement and continuation or discontinuation of ICPI therapy for endocrinopathies ( 2 ). Immune-related endocrinopathies do not fit into a five-tier symptoms

Article Type:
Review Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-22-0513
Volume/Issue:
Volume 12: Issue 5
Open access
Kennett Sprogøe Ascendis Pharma A/S, Hellerup, Denmark

Search for other papers by Kennett Sprogøe in
Google Scholar
PubMed Close
,
Eva Mortensen Ascendis Pharma, Inc., Palo Alto, California, USA

Search for other papers by Eva Mortensen in
Google Scholar
PubMed Close
,
David B Karpf Ascendis Pharma, Inc., Palo Alto, California, USA

Search for other papers by David B Karpf in
Google Scholar
PubMed Close
, and
Jonathan A Leff Ascendis Pharma, Inc., Palo Alto, California, USA

Search for other papers by Jonathan A Leff in
Google Scholar
PubMed Close

-0526 ) 10.1210/jc.2007-0526 6 Pawlikowska-Haddal A . Growth hormone therapy with norditropin (somatropin) in growth hormone deficiency. Expert Opinion on Biological Therapy 2013 13 927 – 932 . ( doi:10.1517/14712598.2013.795941 ) 10

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-17-0203
Volume/Issue:
Volume 6: Issue 8
Open access
M Boering Isala, Diabetes Centre, Zwolle, The Netherlands

Search for other papers by M Boering in
Google Scholar
PubMed Close
,
P R van Dijk Isala, Diabetes Centre, Zwolle, The Netherlands
Isala, Department of Internal Medicine, Zwolle, The Netherlands

Search for other papers by P R van Dijk in
Google Scholar
PubMed Close
,
S J J Logtenberg Diakonessenhuis, Department of Internal Medicine, Utrecht, The Netherlands
Langerhans Medical Research group, Zwolle, The Netherlands

Search for other papers by S J J Logtenberg in
Google Scholar
PubMed Close
,
K H Groenier Isala, Diabetes Centre, Zwolle, The Netherlands
Department of General Practice, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

Search for other papers by K H Groenier in
Google Scholar
PubMed Close
,
B H R Wolffenbuttel Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

Search for other papers by B H R Wolffenbuttel in
Google Scholar
PubMed Close
,
R O B Gans Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

Search for other papers by R O B Gans in
Google Scholar
PubMed Close
,
N Kleefstra Isala, Diabetes Centre, Zwolle, The Netherlands
Langerhans Medical Research group, Zwolle, The Netherlands
Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

Search for other papers by N Kleefstra in
Google Scholar
PubMed Close
, and
H J G Bilo Isala, Diabetes Centre, Zwolle, The Netherlands
Isala, Department of Internal Medicine, Zwolle, The Netherlands
Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

Search for other papers by H J G Bilo in
Google Scholar
PubMed Close

suggested to influence several extra-glycemic, metabolic, and endocrinological parameters, such as the sex hormone-binding globulin (SHBG). SHBG is a glycoprotein produced in the liver, which regulates the bioavailability of sex steroids for target tissues

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-16-0006
Volume/Issue:
Volume 5: Issue 3
Open access
A C Paepegaey Nutrition Department, Assistance-Publique Hôpitaux de Paris (AP-HP), Pitié-Salpêtrière Hospital, French Reference Center for Prader-Willi Syndrome, Sorbonne Université, Paris, France

Search for other papers by A C Paepegaey in
Google Scholar
PubMed Close
,
M Coupaye Nutrition Department, Assistance-Publique Hôpitaux de Paris (AP-HP), Pitié-Salpêtrière Hospital, French Reference Center for Prader-Willi Syndrome, Sorbonne Université, Paris, France

Search for other papers by M Coupaye in
Google Scholar
PubMed Close
,
A Jaziri Nutrition Department, Assistance-Publique Hôpitaux de Paris (AP-HP), Pitié-Salpêtrière Hospital, French Reference Center for Prader-Willi Syndrome, Sorbonne Université, Paris, France

Search for other papers by A Jaziri in
Google Scholar
PubMed Close
,
F Ménesguen Nutrition Department, Assistance-Publique Hôpitaux de Paris (AP-HP), Pitié-Salpêtrière Hospital, French Reference Center for Prader-Willi Syndrome, Sorbonne Université, Paris, France

Search for other papers by F Ménesguen in
Google Scholar
PubMed Close
,
B Dubern Nutrition and Gastroenterology Department, Assistance-Publique Hôpitaux de Paris (AP-HP), Armand Trousseau Children’s Hospital, Paris, France

Search for other papers by B Dubern in
Google Scholar
PubMed Close
,
M Polak Pediatric Endocrinology, Diabetology and Gynecology Department, Assistance-Publique Hôpitaux de Paris (AP-HP), Necker Enfants Malades Hospital University Hospital, Paris, France

Search for other papers by M Polak in
Google Scholar
PubMed Close
,
J M Oppert Nutrition Department, Assistance-Publique Hôpitaux de Paris (AP-HP), Pitié-Salpêtrière Hospital, French Reference Center for Prader-Willi Syndrome, Sorbonne Université, Paris, France

Search for other papers by J M Oppert in
Google Scholar
PubMed Close
,
M Tauber Pediatric Endocrinology Department, Children’s Hospital, French Reference Center for Prader-Willi Syndrome, Toulouse, France

Search for other papers by M Tauber in
Google Scholar
PubMed Close
,
G Pinto Pediatric Endocrinology, Diabetology and Gynecology Department, Assistance-Publique Hôpitaux de Paris (AP-HP), Necker Enfants Malades Hospital University Hospital, Paris, France

Search for other papers by G Pinto in
Google Scholar
PubMed Close
, and
C Poitou Nutrition Department, Assistance-Publique Hôpitaux de Paris (AP-HP), Pitié-Salpêtrière Hospital, French Reference Center for Prader-Willi Syndrome, Sorbonne Université, Paris, France
INSERM, UMRS 1166, Nutriomic Group 6, Paris, France
Sorbonne Université, UMRS1166, Paris, France

Search for other papers by C Poitou in
Google Scholar
PubMed Close

transition   Sex-hormone therapy (%) 20 (21.1) 16 (51.6) 4 (6.3) <0.0001  After transition   Screening (%) § 90 (94.7) 30 (96.8) 60 (93.8) 1   Hypogonadism (%) 82/90 (91.1) 27/30 (90.0) 55/60 (91

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0089
Volume/Issue:
Volume 7: Issue 5
Open access
Lachlan Angus Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, Victoria, Australia

Search for other papers by Lachlan Angus in
Google Scholar
PubMed Close
,
Shalem Leemaqz Robinson Research Institute, Adelaide Medical School, The University of Adelaide, Adelaide, South Australia

Search for other papers by Shalem Leemaqz in
Google Scholar
PubMed Close
,
Olivia Ooi Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, Victoria, Australia

Search for other papers by Olivia Ooi in
Google Scholar
PubMed Close
,
Pauline Cundill Equinox Gender Diverse Clinic, Thorne Harbour Health, Fitzroy, Victoria, Australia

Search for other papers by Pauline Cundill in
Google Scholar
PubMed Close
,
Nicholas Silberstein Equinox Gender Diverse Clinic, Thorne Harbour Health, Fitzroy, Victoria, Australia

Search for other papers by Nicholas Silberstein in
Google Scholar
PubMed Close
,
Peter Locke Equinox Gender Diverse Clinic, Thorne Harbour Health, Fitzroy, Victoria, Australia

Search for other papers by Peter Locke in
Google Scholar
PubMed Close
,
Jeffrey D Zajac Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, Victoria, Australia

Search for other papers by Jeffrey D Zajac in
Google Scholar
PubMed Close
, and
Ada S Cheung Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, Victoria, Australia

Search for other papers by Ada S Cheung in
Google Scholar
PubMed Close

oestradiol as feminising gender-affirming hormone therapy ( 3 ). Goals of therapy are generally to increase serum oestradiol concentrations and lower serum total testosterone concentrations to achieve sex steroid concentrations in the female reference range

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0272
Volume/Issue:
Volume 8: Issue 7
Open access